SC16 - Long-term oncological outcomes of bladder carcinoma in situ (CIS) treated with BCG immunotherapy: prognostic implications of 6-month pathological response assessed by a propensity score matching analysis

Autor: Piana, A., Gallioli, A., Diana, P., Subiela, J.D., Faba, O. Rodriguez, Aumatell, J., Esquinas, C., Huguet, J., Fontana, M., Algaba, F., Palou, J., Breda, A.
Zdroj: In European Urology Open Science October 2021 32 Supplement 1:S8-S9
Databáze: ScienceDirect